Comment in

• Screening for gestational diabetes. What is the no-show rate? [Diabetes Care. 1998]
  Screening for gestational diabetes. What is the no-show rate?Hitchman R, Mathur G, McElduff A. Diabetes Care. 1998 Apr; 21(4):674-5.
• Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria. [Diabetes Care. 2000]
  Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria.Park JY, Kim YI, Choi CS, Chung YE, Kim SW, Lee MS, Lee SI, Hong SK, Lee KU. Diabetes Care. 2000 May; 23(5):707-8.
• Further data on the comparison between World Health Organization and American Diabetes Association diagnostic criteria DIAINF Study Group. [Diabetes Care. 1999]
  Further data on the comparison between World Health Organization and American Diabetes Association diagnostic criteria DIAINF Study Group.Mannucci E, De Bellis A, Cernigoi AM, Tortul C, Rotella CM, Velussi M. Diabetes Care. 1999 Oct; 22(10):1755-7.
• Agreement between old and new diagnostic criteria in postpartum testing of women with gestational diabetes. [Diabetes Care. 1998]
  Agreement between old and new diagnostic criteria in postpartum testing of women with gestational diabetes.Cundy T, Ducker L, Wrathall K, Morrison J. Diabetes Care. 1998 Sep; 21(9):1579-80.
• Poor performance of American Diabetes Association criteria in women with gestational diabetes. [Diabetes Care. 2000]
  Poor performance of American Diabetes Association criteria in women with gestational diabetes.Corcoy R, García-Patterson A, Albareda M, de Leiva A. Diabetes Care. 2000 Mar; 23(3):430-1.
• Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients? [Diabetes Care. 2000]
  Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients?Carreras G, Mauricio D, Pérez A, de Leiva A. Diabetes Care. 2000 Nov; 23(11):1715-6.
• GHb (HbA(1c)) is more sensitive than fasting blood glucose as a screening test for diabetes. [Diabetes Care. 2000]
  GHb (HbA(1c)) is more sensitive than fasting blood glucose as a screening test for diabetes.Papoz L, Favier F, Clabé A, Sanchez A, Le Moullec N. Diabetes Care. 2000 Aug; 23(8):1206-7; author reply 1208.
• American Diabetes Association criteria for diabetes diagnosis. Another perspective. [Diabetes Care. 1999]
  American Diabetes Association criteria for diabetes diagnosis. Another perspective.Somani BL, Bangar SS, Bhalwar R. Diabetes Care. 1999 Feb; 22(2):366.
• HbA(1c) measurements do not improve the detection of type 2 diabetes in a randomly selected population. [Diabetes Care. 2001]
  HbA(1c) measurements do not improve the detection of type 2 diabetes in a randomly selected population.Davidson MB, Schriger DL, Lorber B. Diabetes Care. 2001 Nov; 24(11):2017-8.
• Science: moving us in the right direction. [Diabetes Care. 1997]
  Science: moving us in the right direction.Eastman RC, Vinicor F. Diabetes Care. 1997 Jul; 20(7):1057-8.